Celgene Corp (CELG)
$107.71 0.42 (0.39%)
12:22 EST CELG Stock Quote Delayed 15 Minutes
Previous Close $108.13
Market Cap 76.13B
PE Ratio 30.00
Volume (Avg. Vol.) 14.85M
Day's Range 107.27 - 108.31
52-Week Range 58.59 - 110.70
Dividend & Yield N/A (N/A)
CELG Stock Predictions, Articles, and Celgene Corp News
- From InvestorPlace
- From the Web
Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.
Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.
BMY stock may continue to bounce around, but the months-long selloff is now slowing because Bristol-Myers Squibb is still thriving.
Stock were hit on Thursday as investors try to parse through a deluge of earnings results. Here's what moved the stock market today.
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.
The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
The stock charts of CELG, AAL and MYL stock are going to start the new trading week out in a clear technical condition.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!